Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07198971
Recruiting Not applicable

Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for Cancer

NCT07198971 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-02-18
Last updated
2026-04-09

Condition(s) studied

Cancer (With or Without Metastasis)

Investigational drug(s) / intervention(s)

Music therapy

Music therapy: Music therapy sessions in addition to nursing consultations: creation of a soundtrack to listen to in order to help quit smoking

Study summary

The innovative nature of this project lies in the combination of three types of intervention: tobacco addiction treatment, music therapy and therapeutic education.

Three disciplines that work together.

1. Tobacco addiction treatment: reducing consumption, quitting,
2. Music therapy: acting on emotions and reward circuits,
3. Therapeutic education: promoting independent healthy practices. Patients learn to use the soundtrack independently to help them manage withdrawal symptoms caused by reducing or stopping tobacco consumption.

In this programme, patients play an active role on several levels:

* working with the music therapist to create a personalised 'soundtrack';
* identifying situations in which music can help them manage withdrawal symptoms;
* using music independently in their everyday lives. The music therapy protocol will be proposed in this study, the soundtrack is co-created by the music therapist and the patient based on the patient's musical tastes and needs. The fact that the patient can use the musical tool independently also gives them significant leverage in their withdrawal process, allowing them to act on withdrawal symptoms and the main factors contributing to relapse.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients over the age of 18 2. Patients with tobacco-related or non-tobacco-related cancer (excluding blood cancer) 3. Patients who smoke daily 4. Patients wishing to begin a smoking cessation programme 5. Patients with a prognosis of \> 1 year 6. Patients who have given their informed, written and express consent 7. Patients affiliated with a French social security scheme Exclusion Criteria: 1. Patients with uncorrected hearing loss 2. Patients with unstable psychiatric conditions 3. Patients for whom regular follow-up is impossible for psychological, family, social or geographical reasons 4. Patients under guardianship, curatorship or judicial protection

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institut Du Cancer de Montpellier Montpellier Herault Recruiting

More Institut du Cancer de Montpellier - Val d'Aurelle trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07198971 on ClinicalTrials.gov ↗ ← All trials in France